Category 01
Tobacco and nicotine
Public companies with direct, majority-owned, or economically material exposure to nicotine products or nicotine-led distribution.
Classification and underwriting
- Category definition
- Public companies with direct, majority-owned, or economically material exposure to nicotine products or nicotine-led distribution.
- Inclusion rules
- cigarettes
- cigars
- vaping
- nicotine pouches
- smokeless tobacco
- Exclusion rules
- generic retailers with incidental tobacco shelf space
- Value-chain roles
- manufacturer
- brand owner
- specialist distributor
- Exposure measurement
- Revenue share and product mix across combustible, oral, vapor, and distribution activities.
- Core operating signals
- shipment volume
- pricing and mix
- market share
- excise-tax pass-through
- channel inventory
- Underwriting variables
- category substitution
- pricing power
- distribution reach
- litigation reserves
- debt service
- Failure conditions
- adverse rulemaking
- litigation shock
- tax shock
- volume decline without margin capture
- distribution disruption
- Monitoring triggers
- shipment revisions
- FDA action
- excise-tax changes
- inventory dislocation
- credit deterioration
- Portfolio use
- Mature cash-flow exposure with regulatory, litigation, and secular-volume risk assessed separately.
Tobacco and nicotine company research
Latest annual filing available through SEC EDGAR. Fiscal periods and currencies remain separate.
| Company | Revenue | Operating margin | Net margin | Operating cash flow | Assets | Liabilities | Annual filing |
|---|---|---|---|---|---|---|---|
| MO · ALTRIA GROUP, INC. | USD 23.3 B | 42.5% | 29.8% | USD 9.3 B | USD 35 B | USD 38.5 B | 10-K · 2025-12-31 |
| PM · Philip Morris International Inc. | USD 40.6 B | 36.6% | 27.9% | USD 12.2 B | USD 69.2 B | USD 77.2 B | 10-K · 2025-12-31 |
| BTI · British American Tobacco p.l.c. | GBP 25.6 B | 39% | 30.3% | GBP 6.3 B | GBP 109 B | GBP 61.1 B | 20-F · 2025-12-31 |
| TPB · Turning Point Brands, Inc. | USD 463 M | 20.6% | 12.6% | USD 57.4 M | USD 764 M | USD 392 M | 10-K · 2025-12-31 |
Research coverage only. No row identifies a holding, ranking, recommendation, target price, or performance result.